Increased clonal-initiating capability was reported in HCC cells following chemotherapy in a lower stiffness environment, accompanied by an increase in cancer stem cell positive markers (CD44, CD133, c-kit, CXCR-4, OCT4 and NANOG) [91]. The gene discussed is CXCR4; the disease is hepatocellular carcinoma.